Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions

BACKGROUND: The formation of alloantibodies directed against class I human leukocyte antigens (HLA) continues to be a clinically challenging complication after platelet transfusions, which can lead to platelet refractoriness (PR) and occurs in approximately 5%–15% of patients with chronic platelet s...

Descripción completa

Detalles Bibliográficos
Autores principales: van Osch, Thijs L. J., Pongracz, Tamas, Geerdes, Dionne M., Mok, Juk Yee, van Esch, Wim J. E., Voorberg, Jan, Kapur, Rick, Porcelijn, Leendert, Kerkhoffs, Jean‐Louis H., van der Meer, Pieter F., van der Schoot, C. Ellen, de Haas, Masja, Wuhrer, Manfred, Vidarsson, Gestur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
PLATELETS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828502/
https://www.ncbi.nlm.nih.gov/pubmed/36165642
http://dx.doi.org/10.1111/jth.15898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828502/
https://www.ncbi.nlm.nih.gov/pubmed/36165642
http://dx.doi.org/10.1111/jth.15898

Ejemplares similares